iTeos’ Mission:

  • Discover new mechanisms that cancer cells use to avoid immune recognition and attack by targeting immunometabolism and immunosuppressive cells in the tumor micro-environment
  • Leverage our expertise in small molecule and monoclonal antibody drug development to discover medicines to reverse these newly described mechanisms
  • Build upon our expertise in tumor biology, immunology, drug discovery and early clinical development to provide new and effective therapies for persons with cancer

iTeos’ Discovery Process:

  • Develop innovative platforms to recreate the cellular or metabolic immunosuppressive environment that prevents immune attack of tumor cells
  • Discover therapies that reverse the unique and immunosuppressive cellular and metabolic environment within the tumor microenvironment
  • Test these therapies with in vitro and in vivo models that measure the efficacy of these novel cancer therapeutics